Kao, J., Yu, M., Chen, C., Peng, C., Chen, M., Tang, H., … Wu, J. (2018). Twelve-week Ravidasvir plus ritonavir-boosted Danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.14096 (Original work published 2018)